Lawrence A. Kenyon

CIK: 0001230484

Transaction Breakdown

Open Market Buys (P)2 (66.7%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

OTLK

Outlook Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

OTLK
Outlook Therapeutics, Inc.
Aug 14, 2026
Purchase(P)
Direct
101K shares-
OTLK
Outlook Therapeutics, Inc.
Jul 21, 2026
Award(A)
Stock Option (Right to Buy)
Direct
210.1K shares-
OTLK
Outlook Therapeutics, Inc.
Sep 26, 2024
Purchase(P)
Direct
5K shares at avg. $5.69$28K

		Type	Shares	Price		Ownership
Aug 14, 2026	OTLK Outlook Therapeutics, Inc.	Purchase(P)	101,010	-	$0	Direct
Jul 21, 2026	OTLK Outlook Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	210,078	-	-	Direct
Sep 26, 2024	OTLK Outlook Therapeutics, Inc.	Purchase(P)	5,000	$5.69	$28,446	Direct

1-3 of 3 transactions

About KENYON LAWRENCE A

KENYON LAWRENCE A (SEC CIK 0001230484) files insider reports with the SEC as Chief Financial Officer of Outlook Therapeutics, Inc. (OTLK).

Signal8 holds 3 ownership filings by KENYON LAWRENCE A, all Form 4s, filed between Sep 30, 2024 and Aug 14, 2026. Those filings report 3 transactions, from Sep 26, 2024 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on KENYON LAWRENCE A's filings is in ISELIN, NJ.

Recent filings by KENYON LAWRENCE A

Aug 14, 2026: Open-market purchase of OTLK shares (Form 4, code P).
Jul 21, 2026: Grant or award of OTLK derivative securities (Form 4, code A).
Sep 26, 2024: Open-market purchase of OTLK shares (Form 4, code P).

Other insiders filing for Outlook Therapeutics, Inc. (OTLK)

Lundquist Kevin Michael, Chief Financial Officer
Jahr Robert Charles, Chief Executive Officer
Sukhtian Ghiath M., Director
Sukhtian Faisal Ghiath, Director
Haddadin Yezan Munther, Director
THURMAN RANDY H, Director

How to read Form 4 transaction codes